Additionally, a heterozygote advantage in the context of hepatitis C virus (HCV) infection has been described by Hraber et al. According to their findings, the subjects with HCV infection had much lower percentages of HLA-DRB1 heterozygosity than those without infection. This evidence concerns the gene HLA-DRB1 and infection.